COAs

R&D

It is well documented that women face delayed diagnoses, mischaracterised symptoms, and experience more years of ill-health compared to men.

News

Lundbeck has completed patient randomisation in a pivotal trial of epilepsy candidate bexicaserin, one of its major growth hopes.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.